<?xml version="1.0" encoding="UTF-8"?>
<collection>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd http://dublincore.org/schemas/xmls/qdc/dcterms.xsd"><dc:language>eng</dc:language><dc:creator>Lázaro, Diana F</dc:creator><dc:creator>Amen, Triana</dc:creator><dc:creator>Luk, Kelvin C</dc:creator><dc:creator>Lee, Virginia My-</dc:creator><dc:creator>Outeiro, Tiago</dc:creator><dc:creator>Gerhardt, Ellen</dc:creator><dc:creator>Song, Chengyuan</dc:creator><dc:creator>Burns, Ryan</dc:creator><dc:creator>Kruse, Niels</dc:creator><dc:creator>Santos, Patrícia I</dc:creator><dc:creator>Milovanovic, Dragomir</dc:creator><dc:creator>Höglinger, Günter</dc:creator><dc:creator>Mollenhauer, Brit</dc:creator><dc:title>Synphilin-1 modulates alpha-synuclein assembly, release and uptake.</dc:title><dc:subject>info:eu-repo/classification/ddc/610</dc:subject><dc:description>Alpha-synuclein (aSyn) is an intrinsically disordered protein involved in phase separation and several age-associated neurodegenerative disorders, including Parkinson's disease. However, its function and pathological role remain elusive. Here, we modeled different aSyn assemblies in living cells by exploiting its interaction with synphilin-1 (Sph1). We developed a model that reports on gel- and solid-like inclusions through coexpression of aSyn and Sph1. Distinct morphological differences emerged between VN-aSyn + aSyn-VC and VN-Sph1 + aSyn-VC assemblies, showing unique antibody recognition, proteinase K resistance, and protein mobilities. The VN-Sph1 + aSyn-VC interaction could be manipulated to alter inclusion size and number. These inclusions also contained lysosomes and AP-1 vesicles, aligning with observations in human brain tissue. Our study offers new insight into aSyn aggregation and release, highlighting the importance of Sph1 and other aSyn-interacting proteins in synucleinopathies, which involve diverse copathologies only now beginning to be understood.</dc:description><dc:source>npj Parkinson's Disease 11(1), 326 (2025). doi:10.1038/s41531-025-01144-3</dc:source><dc:type>info:eu-repo/semantics/article</dc:type><dc:type>info:eu-repo/semantics/publishedVersion</dc:type><dc:publisher>Springer Nature</dc:publisher><dc:date>2025</dc:date><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:coverage>DE</dc:coverage><dc:identifier>https://pub.dzne.de/record/282474</dc:identifier><dc:identifier>https://pub.dzne.de/search?p=id:%22DZNE-2025-01297%22</dc:identifier><dc:audience>Researchers</dc:audience><dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1038/s41531-025-01144-3</dc:relation><dc:relation>info:eu-repo/semantics/altIdentifier/issn/2373-8057</dc:relation><dc:relation>info:eu-repo/semantics/altIdentifier/pmid/pmid:41266386</dc:relation></oai_dc:dc>

</collection>